The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
Open accessAbstract
Atherosclerosis (AS), the underlying cause of most cardiovascular events, is one of the most common causes of human morbidity and mortality worldwide due to the lack of an efficient strategy for targeted therapy.In this work, we aimed to develop an ideal biomimetic nanoparticle for targeted AS therapy.Methods: Based on macrophage "homing" into atherosclerotic lesions and cell membrane coating nanotechnology, biomimetic nanoparticles (MM/RAPNPs) were fabricated with a macrophage membrane (MM) coating on the surface of rapamycin-loaded poly (lactic-co-glycolic acid) copolymer (PLGA) nanoparticles (RAPNPs).Subsequently, the physical properties of the MM/RAPNPs were characterized.The biocompatibility and biological functions of MM/RAPNPs were determined in vitro.Finally, in AS mouse models, the targeting characteristics, therapeutic efficacy and safety of the MM/RAPNPs were examined.Results: The advanced MM/RAPNPs demonstrated good biocompatibility.Due to the MM coating, the nanoparticles effectively inhibited the phagocytosis by macrophages and targeted activated endothelial cells in vitro.In addition, MM-coated nanoparticles effectively targeted and accumulated in atherosclerotic lesions in vivo.After a 4-week treatment program, MM/RAPNPs were shown to significantly delay the progression of AS.Furthermore, MM/RAPNPs displayed favorable safety performance after long-term administration.Conclusion: These results demonstrate that MM/RAPNPs could efficiently and safely inhibit the progression of AS.These biomimetic nanoparticles may be potential drug delivery systems for safe and effective anti-AS applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“target is one of the major hurdles that almost all platforms must overcome [13-15].”
BackgroundInflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García-Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,476
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Vascular smooth muscle cells in atherosclerosis
Bennett, M. R., Sinha, S., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306361 · Cited by 2,179
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Self-citationHerrington, W., Lacey, B., Sherliker, P., Armitage, J., & Lewington, S. (2016) · Circulation Research · doi:10.1161/circresaha.115.307611 · Cited by 1,469
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Recent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016 · cited 1×
“, VCAM-1) and secrete chemokines to recruit circulating monocyte macrophages and promote them to traverse the subendothelial space and migrate into the intimal layer [55,56].”
BackgroundMinimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Zhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
The role of macrophages in the resolution of inflammation
Watanabe, S., Alexander, M., Misharin, A. V., & Budinger, G. R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124615 · Cited by 925
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890
Li, S.-Y., Cheng, H., Xie, B.-R., Qiu, W.-X., Zeng, J.-Y., Li, C.-X., Wan, S.-S., Zhang, L., Liu, W.-L., & Zhang, X.-Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b02533 · Cited by 780
Macrophages in inflammation, repair and regeneration
Oishi, Y., & Manabe, I. (2018) · International Immunology · doi:10.1093/intimm/dxy054 · Cited by 734
Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
Cao, H., Dan, Z., He, X., Zhang, Z., Yu, H., Yin, Q., & Li, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b03148 · Cited by 694
Gao, C., Huang, Q., Liu, C., Kwong, C. H. T., Yue, L., Wan, J.-B., Lee, S. M. Y., & Wang, R. (2020) · Nature Communications · doi:10.1038/s41467-020-16439-7 · Cited by 630
Thamphiwatana, S., Angsantikul, P., Escajadillo, T., Zhang, Q., Olson, J., Luk, B. T., Zhang, S., Fang, R. H., Gao, W., Nizet, V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714267114 · Cited by 563
The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging
Kennedy, B. K., & Lamming, D. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.009 · Cited by 544
Understanding and Overcoming Major Barriers in Cancer Nanomedicine
Nie, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.23 · Cited by 498
Cell or Cell Membrane-Based Drug Delivery Systems
Tan, S., Wu, T., Zhang, D., & Zhang, Z. (2015) · Theranostics · doi:10.7150/thno.11852 · Cited by 466
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 437
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Raggi, P., Genest, J., Giles, J. T., Rayner, K. J., Dwivedi, G., Beanlands, R. S., & Gupta, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.014 · Cited by 433
Safety and efficacy of statin therapy
Adhyaru, B. B., & Jacobson, T. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0098-5 · Cited by 424
Jiang, Q., Liu, Y., Guo, R., Yao, X., Sung, S., Pang, Z., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.021 · Cited by 398
Xuan, M., Shao, J., Dai, L., Li, J., & He, Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00853 · Cited by 376
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz6108 · Cited by 363
Wang, Y., Li, L., Zhao, W., Dou, Y., An, H., Tao, H., Xu, X., Jia, Y., Lu, S., Zhang, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02037 · Cited by 361
Self-citationMacrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
Xuan, M., Shao, J., Dai, L., He, Q., & Li, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500129 · Cited by 352
Wei, X., Ying, M., Dehaini, D., Su, Y., Kroll, A. V., Zhou, J., Gao, W., Fang, R. H., Chien, S., & Zhang, L. (2018) · ACS Nano · doi:10.1021/acsnano.7b07720 · Cited by 329
Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles
Li, R., He, Y., Zhu, Y., Jiang, L., Zhang, S., Qin, J., Wu, Q., Dai, W., Shen, S., Pang, Z., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03439 · Cited by 328
Synthesis and Biomedical Applications of Multifunctional Nanoparticles
Kim, D., Shin, K., Kwon, S. G., & Hyeon, T. (2018) · Advanced Materials · doi:10.1002/adma.201802309 · Cited by 317
Wang, Y., Zhang, K., Qin, X., Li, T., Qiu, J., Yin, T., Huang, J., McGinty, S., Pontrelli, G., Ren, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201900172 · Cited by 314
Self-citationEngineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
Yan, H., Shao, D., Lao, Y., Li, M., Hu, H., & Leong, K. W. (2019) · Advanced Science · doi:10.1002/advs.201900605 · Cited by 240
Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
Zhou, L., Wang, H., & Li, Y. (2018) · Theranostics · doi:10.7150/thno.22679 · Cited by 232
Song, Y., Huang, Z., Liu, X., Pang, Z., Chen, J., Yang, H., Zhang, N., Cao, Z., Liu, M., Cao, J., et al. (2019) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.08.002 · Cited by 203
Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis
Kim, Y., Lobatto, M. E., Kawahara, T., Lee Chung, B., Mieszawska, A. J., Sanchez-Gaytan, B. L., Fay, F., Senders, M. L., Calcagno, C., Becraft, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322725111 · Cited by 189
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation
Boada, C., Zinger, A., Tsao, C., Zhao, P., Martinez, J. O., Hartman, K., Naoi, T., Sukhovershin, R., Sushnitha, M., Molinaro, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315185 · Cited by 186
Tang, T.-T., Lv, L.-L., Wang, B., Cao, J.-Y., Feng, Y., Li, Z.-L., Wu, M., Wang, F.-M., Wen, Y., Zhou, L.-T., et al. (2019) · Theranostics · doi:10.7150/thno.33520 · Cited by 163
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 158
Bender, E. A., Adorne, M. D., Colomé, L. M., Abdalla, D. S. P., Guterres, S. S., & Pohlmann, A. R. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.051 · Cited by 154
Principles of Nanoparticle Design for Overcoming Biological Barriers to Drug Delivery *
Blanco, E., Shen, H., & Mauro Ferrari, B. (2020) · doi:10.1201/9780429027819-9 · Cited by 149
Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis
Dou, Y., Chen, Y., Zhang, X., Xu, X., Chen, Y., Guo, J., Zhang, D., Wang, R., Li, X., & Zhang, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.035 · Cited by 134
Lobatto, M. E., Calcagno, C., Millon, A., Senders, M. L., Fay, F., Robson, P. M., Ramachandran, S., Binderup, T., Paridaans, M. P. M., Sensarn, S., et al. (2015) · ACS Nano · doi:10.1021/nn506750r · Cited by 133
Biomimetic nanoparticle technology for cardiovascular disease detection and treatment
Park, J. H., Dehaini, D., Zhou, J., Holay, M., Fang, R. H., & Zhang, L. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00291j · Cited by 130
Applications of Nanoparticles in Nanomedicine
Yohan, D., & Chithrani, D. B. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.2015 · Cited by 122
Recent Advances in Managing Atherosclerosis via Nanomedicine
Chan, C. K. W., Zhang, L., Cheng, C. K., Yang, H., Huang, Y., Tian, X. Y., & Choi, C. H. J. (2017) · Small · doi:10.1002/smll.201702793 · Cited by 119
Nanobiotechnology: Cell membrane-based delivery systems
Zhang, P., Liu, G., & Chen, X. S. (2016) · Nano Today · doi:10.1016/j.nantod.2016.10.008 · Cited by 112
A Targeting Nanotherapy for Abdominal Aortic Aneurysms
Cheng, J., Zhang, R., Li, C., Tao, H., Dou, Y., Wang, Y., Hu, H., & Zhang, J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2188 · Cited by 109
Self-citationLi, C., Dou, Y., Chen, Y., Qi, Y., Li, L., Han, S., Jin, T., Guo, J., Chen, J., & Zhang, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002131 · Cited by 95
Chen, W. Q., Zhong, L., Zhang, L., Ji, X. P., Zhang, M., Zhao, Y. X., Zhang, C., & Zhang, Y. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00102.x · Cited by 93
Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications
Ai, X., Hu, M., Wang, Z., Zhang, W., Li, J., Yang, H., Lin, J., & Xing, B. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00103 · Cited by 78
Preparation of Particulate Polymeric Therapeutics for Medical Applications
Zhuang, J., Fang, R. H., & Zhang, L. (2017) · Small Methods · doi:10.1002/smtd.201700147 · Cited by 42
Acid-Activated Melittin for Targeted and Safe Antitumor Therapy
Luo, L., Wu, W., Sun, D., Dai, H.-B., Wang, Y., Zhong, Y., Wang, J.-X., Maruf, A., Nurhidayah, D., Zhang, X., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00352 · Cited by 38
Self-citationMacrophages and Their Contribution to the Development of Atherosclerosis
Bobryshev, Y. V., Nikiforov, N. G., Elizova, N. V., & Orekhov, A. N. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-54090-0_11 · Cited by 33
Impact of Macrophages in Atherosclerosis
Lu, X. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160428105111 · Cited by 14
Dou, Y., Zhang, X., Xu, X., Zhou, X. W., Han, S., Wang, R., Su, M., Li, X., & Zhang, J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01474c · Cited by 11
Multifaceted functions of macrophages in atherosclerosis
Wu, C.-H., Daugherty, A., & Lu, H. S. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000513 · Cited by 4
Cited by
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Sun, W., Xu, Y., Yao, Y., Yue, J., Wu, Z., Li, H., Shen, G., Liao, Y., Wang, H., & Zhou, W. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01296-x · Cited by 81
Sun, J., Ju, F., Jin, J., Wang, H. L., Li, Z. J., Sun, Y. C., Chen, Q. Z., Yang, Q. Q., Tan, J., & Zhou, Y. L. (2023) · Small · doi:10.1002/smll.202300326 · Cited by 41
Metadata
- Authors
- Wang, Y., Zhang, K., Li, T., Maruf, A., Qin, X., Luo, L., Zhong, Y., Qiu, J., McGinty, S., Pontrelli, G., Liao, X., Wu, W., & Wang, G.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2021
- Volume
- 11
- Issue
- 1
- Pages
- 164-180
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3092269784
- Cited by
- 409
- References
- 61
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.